The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

Advancements and Projections in the Medical Tapes and Bandages Market: Insights, Trends, Opportunities, and Recent ...

Advancements and Projections in the Pediatric Medical Device Market: Insights, Trends, Opportunities, and Recent ...

After examining Johnson & Johnson, the following trends can be inferred: A Price to Earnings ratio of 24.93 significantly below the industry average by 0.75x suggests undervaluation. This can make the ...

Pharmaceutical and medical device company Johnson & Johnson announced it is acquiring cardiovascular device manufacturer Shockwave Medical Inc. for roughly $13.1 billion (net of cash at the target).

We recently compiled a list of the Best Future Stocks For The Long-Term. In this article, we will look at where Johnson & ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks for beginners with little money. “In my view, for most people, the best thing to do ...

Two of the simplest ways to measure the success of companies that develop and commercialize drugs is to count their approvals ...

PORTLAND, MT, UNITED STATES, September 9, 2024 /EINPresswire / -- Increase in prevalence of chronic diseases, supportive initiatives from medical < ...

Johnson & Johnson has announced that the US FDA has approved TREMFYA for the treatment of active ulcerative colitis (UC).

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...